Since the surge of the coronavirus pandemic all over the world, many are forced to resort to remote working and learning to prevent contracting and spreading the disease. As alternative working spaces are being sought after to maintain productivity, a psychologist says working from the comfort of one’s bed may be good.
Aside from having to work remotely or from home, the coronavirus pandemic has also affected the mental health of many, including those who are already suffering from related issues. Many have experienced worse bouts of their mental health issues take effect, which has also affected the way they work. According to new research, a way to maintain productivity and better mental health is by working from bed. This study was done by UK mattress brand OTTY, who conducted a survey and found that 25 percent of people spent a day working from bed during the lockdown.
They also found that a little before the announcement of the second lockdown, more people were working in their beds. The brand consulted with many experts and chiropractors to look into this method and found that there are benefits to working from the comfort of the bed. Such benefits include less stress due to the peaceful environment created by being in bed.
“Working from the comfort of your bed can create a safe calming space, particularly when anxiety is an issue,” said Kerry Quigley, a British Association for Counselling and Psychotherapy-accredited expert. “It can eliminate stressors such as commuting, distractions, and workplace politics. The removal of these stressors and the autonomy to structure your day enables better time management, increasing productivity, and improving job satisfaction.”
At the same time, pharmaceutical companies are determined to produce a coronavirus vaccine. However, as prevention is better than a cure, scientists are also looking into prevention methods in order to keep pandemics from happening in the future. Several scientists have recently brought up the technique of gene altering to give a person immunity from potential pandemic-causing diseases.
The technique may be through a few methods such as the CRISPR or CRISPER-Cas9, which would involve scientists editing the genome by altering the DNA. Another method is to “scramble” the genetic code that will result in the disabling of coronaviruses.


Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Neuralink Expands Brain Implant Trials with 12 Global Patients
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Tabletop particle accelerator could transform medicine and materials science
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 



